|Dye Color||Red (Emmax 647-700 nm)|
|Emission Wavelength Maximum||672 nm|
|Extinction Coefficient at Absorbance Max||270,000|
|Absorption Wavelength Maximum (Abs. Max)||651 nm|
|Application||Antisense/RNAi, Aptamers, CRISPR|
|Oligo Modification Type||Fluorescent Dye (Red)|
Alexa & Premium Dyes These materials and products incorporating them are provided under an intellectual property license from Life Technologies Corporation. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product for its internal research or internal quality control testing purposes, where such research or internal quality control testing does not include testing, analysis or screening services for any third party in return for compensation on a per test basis. The buyer cannot sell or otherwise transfer (a) this product (b) its components or (c) materials made using this product or its components to a third party or otherwise use this product or its components or materials made using this product or its components for Commercial Purposes. Commercial Purposes means any activity by a party for consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing, except for quality control or quality assurance purposes; (2) use of the product or its components to provide a service, information, or data, except for quality control or quality assurance purposes; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad, CA 92008 USA or [email protected]
Rychahou, Piotr; Haque, Farzin; Shu, Yi; Zaytseva, Yekaterina; Weiss, Heidi L.; Lee, Eun Y.; Mustain, William; Valentino, Joseph; Guo, Peixuan; Evers, B. Mark . Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.